Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806409 | SCV000946405 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507396 | SCV002814865 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2022-05-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004962827 | SCV005552812 | likely benign | Inborn genetic diseases | 2024-10-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |